Secondary Reference Standards: complete with characterization (UV, IR, 1H NMR, 13C NMR, Mass Spec), purity and assay with validated HPLC method and specification using pharmacopoeia Primary Reference Standard for APIs with monograph or chemical literature for APIs without monograph. For available Secondary Reference Standards approved by the Ministry of Health see our catalogue (Download). For other Secondary Reference Standards please contact our sales department:
email: Sales@Andishehct.com
phone: +9821 8849 7298, +98 922 268 9092
• Process Development: for APIs based on client’s specifications
• Resolution of Enantiomers: as per our proprietary method (ACS Omega 2017, 2, 8717−8722; US Patent Application 2019/0211150A1, July 11, 2019)
• Isolation of mAbs: facilitated downstream process for the isolation of mAbs based on our proprietary process (ACS Omega , ACS Omega, 2021, doi: 10.1021/acsomega.0c06149; US Patent Application 2022/0411463 A1, December 29, 2022)
• Synthesis of Drug-Antibody Conjugates: based on our proprietary process (ACS Omega , ACS Omega, 2021, doi: 10.1021/acsomega.0c06149; US Patent Application 2022/0411463 A1, December 29, 2022)